Related with this, there are recent efforts to assess the effectiveness of specific inhibitors of cytokine pathways on an increased NIS expression and radioiodide transport function in advanced thyroid cancers (77). This evidence concerns the gene SLC5A5 and thyroid gland carcinoma.